Cancer clinical trials in the region Nouvelle-Aquitaine
454 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
#NCT04104776
#2023-508002-20-00
Required histologic types
B cell lymphoma
T cell lymphoma
Required histologic sub types
Large B cell lymphoma
Peripheral T cell lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
Allogeneic stem cell transplant
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2
Endometrial cancer
#NCT04104776
#2023-508002-20-00
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded genetic anomalies
ARID1A
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04104776
#2023-508002-20-00
Required histologic types
Epithelial ovarian cancer
Required histologic sub types
Clear cell carcinoma
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
ARID1A
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
#2023-508002-20-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2
Lymphoma
#NCT06090539
Required histologic types
B cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
7 recruiting sites
Bristol-Myers Squibb
Phase 1 / Phase 2
Brain tumors / Central nervous system tumors
#NCT07243470
#2023-510568-11-00
Cohorte autre tumeurs du SNC
Required histologic types
Other primary CNS tumor
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Radiotherapy
Excluded previous treatments
Bevacizumab
7 recruiting sites
Centre Léon Bérard
Phase 1 / Phase 2
Brain tumors / Central nervous system tumors
#NCT07243470
#2023-510568-11-00
Cohorte gliome IDH-muté
Required histologic types
Gliomas
Required histologic sub types
High-grade glioma
Required genetic anomalies
IDH1/2
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Radiotherapy
Excluded previous treatments
Bevacizumab
7 recruiting sites
Centre Léon Bérard
Phase 1 / Phase 2
Brain tumors / Central nervous system tumors
#NCT07243470
#2023-510568-11-00
Cohorte autres gliomes
Required histologic types
Gliomas
Required histologic sub types
High-grade glioma
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Radiotherapy
Excluded genetic anomalies
IDH1/2
Excluded previous treatments
Bevacizumab
7 recruiting sites
Centre Léon Bérard
Phase 1 / Phase 2
Liver and bile duct cancer
#NCT07291076
#2025-523602-33-00
Required histologic sub types
Hepatocellular carcinoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Bristol-Myers Squibb
Phase 1 / Phase 2
Amyloidosis
#NCT06158854
Required histologic types
AL Amyloidosis
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Monoclonal antibodies
Proteasome inhibitor
Required organ involvement status
Presence
Required Mayo Clinic stages
Stade I
Stade II
Stade IIIA
Excluded previous treatments
Systemic Treatment-Naive
2 recruiting sites
Abbvie